Dataset | Source | Tissue | Cancer type level1 | Cancer type level2 | Drug type | Regimen | Timepoint | Cell type | avg_log2FC | p_val_adj |
PMID34715028 | patients | Tumor tissue | Kidney cancer | Clear cell renal cell carcinoma (ccRCC) | Immunotherapy | nivolumab | post | CD4+ T cells | 0.273475 | 1.06e-31 |
GSE207422_Sin | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | CD4+ T cells | 0.275838 | 2.05e-10 |
GSE207422_Sin | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | CD8+ T cells | 0.263001 | 5.25e-11 |
GSE207422_Sin | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | NK cells | -0.452663 | 1.17e-02 |
GSE207422_Tor | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | CD4+ T cells | -0.282806 | 8.81e-09 |
GSE207422_Tor | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | CD8+ T cells | -0.260282 | 6.86e-13 |
GSE175716 | PDX | Tumor tissue | Liver cancer | Advanced hepatocellular carcinoma | Targeted therapy | sorafenib | NA | Malignant cells | -0.33803 | 3.05e-36 |
Gene symbol | motif | TF_highConf |
ORMDL3 | tfdimers__MD00002 | CRX (directAnnotation). |
ORMDL3 | tfdimers__MD00280 | E2F1; OTX1; OTX2 (directAnnotation). |
ORMDL3 | transfac_pro__M05974 | ZNF701 (directAnnotation). |
ORMDL3 | transfac_pro__M05756 | ZNF470 (directAnnotation). |
ORMDL3 | transfac_pro__M05379 | ZNF740 (inferredBy_Orthology). |
ORMDL3 | metacluster_74.8 | HNF1B (directAnnotation). |
ORMDL3 | transfac_pro__M05501 | ZBTB8B (directAnnotation). |
ORMDL3 | taipale_cyt_meth__ZNF250_NTAGGCCTAN_eDBD_meth_repr | ZNF250 (directAnnotation). |
ORMDL3 | transfac_pro__M05856 | ZNF565 (directAnnotation). |
ORMDL3 | swissregulon__hs__GATA3 | GATA3 (directAnnotation). |
ORMDL3 | taipale_tf_pairs__POU2F1_FOXO6_RMATATKCNNNNNNNNNNNNNRWMAACA_CAP_repr | FOXO6; POU2F1 (directAnnotation). |
ORMDL3 | taipale_tf_pairs__FOXO1_SPDEF_WMSCGGATGTKNW_CAP_repr | FOXO1; SPDEF (directAnnotation). |
ORMDL3 | metacluster_74.7 | HNF1B (directAnnotation). |
ORMDL3 | tfdimers__MD00128 | CDX2; PDX1 (directAnnotation). |
ORMDL3 | transfac_pro__M06162 | ZNF93 (directAnnotation). |
ORMDL3 | transfac_pro__M06224 | ZNF415 (directAnnotation). |
ORMDL3 | metacluster_106.2 | ZBTB32 (directAnnotation). |
ORMDL3 | metacluster_74.13 | HNF1A; HNF1B (directAnnotation). |
ORMDL3 | tfdimers__MD00394 | CDX2; PAX4 (directAnnotation). |
ORMDL3 | transfac_pro__M12556 | ETV4 (directAnnotation). |
ORMDL3 | homer__VVRRAACAATGG_Sox7 | SOX7 (inferredBy_Orthology). |
ORMDL3 | taipale_cyt_meth__JUND_NRTGACGCATN_eDBD_repr | JUND (directAnnotation). |
ORMDL3 | metacluster_70.14 | POU2F3 (directAnnotation). |
ORMDL3 | swissregulon__mm__Pbx1 | PBX1 (inferredBy_Orthology). |
ORMDL3 | metacluster_64.12 | RARA (directAnnotation). |
ORMDL3 | cisbp__M01813 | CREBZF (inferredBy_Orthology). |
ORMDL3 | metacluster_70.15 | POU2F2 (directAnnotation). |
ORMDL3 | transfac_pro__M04930 | FOXA1 (directAnnotation). |
ORMDL3 | transfac_pro__M00731 | RUNX2 (directAnnotation). |
ORMDL3 | hocomoco__BPTF_HUMAN.H11MO.0.D | BPTF (directAnnotation). |
ORMDL3 | taipale_tf_pairs__ELK1_FOXI1_RSCGGAANNRTMAAYAN_CAP_repr | ELK1; FOXI1 (directAnnotation). |
ORMDL3 | taipale_tf_pairs__MYBL1_ELF1_NMCCGGAACCGTTR_CAP_repr | ELF1; MYBL1 (directAnnotation). |
ORMDL3 | transfac_pro__M06440 | ZNF493 (directAnnotation). |
ORMDL3 | transfac_pro__M02084 | RUNX1 (directAnnotation). |
ORMDL3 | transfac_pro__M04622 | NR4A1 (directAnnotation). |
ORMDL3 | taipale_tf_pairs__GCM1_ETV7_NTNNNGGCGGAAGNNNTTCCNNN_CAP_repr | ETV7; GCM1 (directAnnotation). |
ORMDL3 | swissregulon__hs__GMEB2 | GMEB2 (directAnnotation). |
ORMDL3 | taipale_tf_pairs__ERF_HOXA3_RSCGGAWNNNNNNNYMATTA_CAP_repr | ERF; HOXA3 (directAnnotation). |
1 | "Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618." |
2 | "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335." |